Treatment Registry
TR-0279 ActiveRecorded September 2, 2026

Brand tirzepatide

Sold by AM Rx · Injection, pen · every brand tirzepatide record

What you actually pay

Per month

$64

Medication · With insurance, copay as low as$25
Required membership$39

Added from the figures recorded below.

Price

TermPer monthCharged today
With insurance, copay as low as

When coverage is approved, some members may pay as little as $25 per month in copays, depending on their insurance plan.

source

Per month$25Charged today$25
Visit AM Rx

We earn nothing from this link. AM Rx has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

PrescriberBoth
Cancellation“You can cancel your membership at any time directly through your AM Rx portal. Simply go to your profile, select “Manage membership,” then choose “Manage plan” to complete the cancellation.”
MembershipRequired. $39 per month. “Your first month of membership is currently discounted to $39 and includes personalized medical care, one-on-one coaching, and support from our insurance coordination team to help obtain coverage for prescribed medications when possible.”

Not yet checked: pharmacy, states and consult fee.

Recorded from getamrx.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026AM Rx's FAQ text is nearly word-for-word identical to RoenRx's (same $39 membership, $151/$216 compounded prices, $297/$449 bundle prices), and it too contains leftover "Zealthy" branding ("Most Zealthy members will start on a compound GLP-1...", "Your Zealthy treatment plan starts here", a footer link "Join the Zealthy provider team", and app links pointing to app.getzealthy.com) -- strong evidence AM Rx and RoenRx are both white-label storefronts on the same underlying Zealthy platform. No states-served statement found on this site (unlike RoenRx's homepage claim of all 50 states + DC).

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0279
Readings
1

Related records

What else AM Rx sells

All AM Rx programs and terms

Brand tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 59 records of the same molecule.

Cite this entry

Treatment Registry. (2026). AM Rx brand tirzepatide (TR-0279). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0279

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.